cholecystokinin and Pheochromocytoma

Using sequence-specific radioimmunoassays before and after cleavage with trypsin and carboxypeptidase B, we have examined the occurrence and molecular nature of cholecystokinin (CCK) and gastrin peptides in bioactive (i.e. alpha-carboxyamidated) as well as non-amidated precursor forms in extracts from 13 human pheochromocytomas. All but one tumour contained amidated CCK, but only in moderate amounts (less than or equal to 20 pmol/g tissue). In contrast to the complete sulphation in tissues which normally produce CCK (the brain and small intestine), the amidated adrenal CCK peptides were poorly sulphated (less than or equal to 17%). Four pheochromocytomas, including the one without amidated CCK, contained between 28 and 0.2 pmol amidated gastrin/g, mainly in the form of sulphated gastrin-17. In addition, all tumours contained biosynthetic precursors of both CCK and gastrin. In most extracts there was more precursor than bioactive peptide(s), the progastrin concentration ranging up to 338 pmol/g. The results show that pheochromocytomas synthesize CCK and gastrin. The posttranslational processing differs, however, markedly from that of the principal CCK and gastrin producing tissues, with respect to both proteolytic cleavages and amino acid derivatization. This emphasizes that accurate quantitation in tumours requires assays which measure the translation products irrespective of their degree of processing.

Topics: Adrenal Gland Neoplasms; Amides; Amino Acid Sequence; Cholecystokinin; Chromatography, Gel; Gastrins; Humans; Pheochromocytoma; Radioimmunoassay; Sulfates

Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Biopsy, Needle; Calcitonin; Cholecystokinin; Ethanol; Evaluation Studies as Topic; Female; Humans; Male; Methods; Middle Aged; Multiple Endocrine Neoplasia; Parathyroid Neoplasms; Pentagastrin; Pheochromocytoma; Prognosis; Radionuclide Imaging; Syndrome; Thyroid Neoplasms